|| Hong Kong receives second cross-border cord blood transfer to treat girl, 5

AI Summary:

---------------

---------------

Dr Frankie Cheng Wai-tsoi, of the hospital’s paediatric haematology and oncology team, on Thursday expressed gratitude to both mainland Chinese and Hong Kong authorities for the smooth and efficient transfer process.

“We shall make necessary preparations in the next few months with the transplant expected to be in October,” Cheng said. “We also need to let the patient get prepared.”

While this is the first time the hospital has received cord blood from across the border, the transfer is the city’s second cross-border transport of cord blood from Guangdong to Hong Kong.

The first time was in 2018 when a younger sister’s cord blood was sent to Hong Kong to treat her then seven-year-old elder sister who had severe thalassemia.

A call for assistance to the Guangdong side for the transfer of the cord blood of the patient’s younger brother was made last month, and a formal application for the cross-border transfer was approved last Thursday, in three working days, according to the mainland blood bank.

Arrangements were made to transfer the blood unit from Guangzhou on Thursday morning and it reached the Children’s Hospital in Hong Kong around noon.

Dr Daniel Cheuk Ka-leung, consultant of the hospital’s department of paediatrics and adolescent medicine, said his team “initiated a lot of communications”.

“We made sure that the quality and the results of testing of the cord blood matched our standard,” he said. “Then we proceeded to arrange for all the procedures, all the paperwork to get the permit to transport the cord blood to Hong Kong.”

Cheuk added that the hospital usually searches for cord blood on a local database organised by the Hong Kong Red Cross, but decided to accept a cross-border transfer as sibling donors were preferred.

The girl who received the cord blood donation was born in Shanwei city of eastern Guangdong province in 2019, according to the mainland blood bank. At four months old, blood tests confirmed she suffered from a severe form of Thalassemia.

Her younger brother, who was born in Shanwei about a year later, had his cord blood stored.

In 2022, the mother relocated to Hong Kong with her two children and reunited with the father. The girl has since been treated in the city.

Thalassemia is a blood disorder that is inherited, passed down from one or both parents through their genes. It causes the body to make less haemoglobin than normal. Haemoglobin is an iron-rich protein in red blood cells and it carries oxygen to all parts of the body.

Thalassemia can cause anaemia and patients are susceptible to feeling fatigued.

Patients having mild thalassemia do not need blood transfusions, but they may need to take supplemental vitamins to help treat anaemia.

However, more severe cases of the condition would require regular blood transfusions. Stem cell transplant is also a preferred option as it can eliminate the need for lifelong blood transfusions.

Transplants will typically involve receiving infusions of stem cells from a compatible donor, usually a sibling or close relatives.

According to Cheuk, the hospital treated about 40 to 50 thalassemia cases on average every year.

“Among them, two or three are more severe forms and stem cell transplants is the most preferred treatment. It can cure the condition and there is no need for the patient to have regular blood transfusions,” Cheuk said.

via News - South China Morning Post (author: Ng Kang-chung)
 
 
Back to Top